Naftidrofuryl

DB13588ApprovedSmall molecule

Naftidrofuryl is a peripheral vasodilator indicated in the treatment of chronic venous ulcers. A medication used to treat varicose veins.

Chemical structure of Naftidrofuryl
Mechanism
Curator reviewed
Formula / weight
C24H33NO3 · 383.5237 g/mol (avg)
Also known as
Nafronyl
Code names
LS-84

Resolves to

Compound
UNII42H8PQ0NMJCAS31329-57-4ChEMBLCHEMBL1620794ChEBI91817PubChem4417
Clinical / RWD
RxNorm7236ATCC04AX21
Structure
InChIKeyKBAFPSLPKGSANY-UHFFFAOYSA-NSMILESCCN(CC)CCOC(=O)C(CC1CCCO1)CC1=CC=CC2=C1C=CC=C2
Targets
P28223HTR2A

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
683Drug interactionsStructured to mechanism, not free text
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
26Marketed productsAcross 5 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Naftidrofuryl, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In